News
Companies are not yet rushing to relocate production to the US, but investment and dealmaking have already slowed ...
Second, SoFi could grow its revenue even without expanding its membership base, by cross-selling additional products to its ...
Merck & Co., Inc. (NYSE:MRK) ranks among the best set-it-and-forget-it stocks to buy. On June 27, TD Cowen maintained its ...
From health to hair care, the experts broke down exactly how artificial intelligence is shaping Black futures and why we can’t afford to sit this one out.
Over the last 7 days, the United States market has risen 2.1%, contributing to a notable 14% climb over the past year, with earnings expected to grow by 15% annually. In this favorable environment, ...
In Hazle Twp. on the end of a road in Humboldt Industrial Park, Michaels Stores wants to make its distribution center part of ...
LONDON, GREATER LONDON, UNITED KINGDOM, July 4, 2025 /EINPresswire.com/ -- The anti-inflammatory drugs market size has grown rapidly in recent years. From $136.86 billion in 2024, it is predicted to ...
22h
Independent.ie on MSNArthur Cox and A&L Goodbody lead way for M&A activityLaw firms A&L Goodbody and Arthur Cox are the two big legal winners from continuing mergers and acquisitions activity linked ...
The best-financed lobbyists in the United States are protecting the pharmaceutical sector, but that may change ...
12h
Zacks Investment Research on MSNWill Novo Nordisk's Rare Disease Bets Reduce GLP-1 Reliance?Novo Nordisk NVO has experienced remarkable growth in recent years, largely fueled by the commercial success of its ...
10h
The Manila Times on MSNAstraZeneca eyes licensing lung cancer drugASTRAZENECA is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal worth as much as $15 billion, Bloomberg News reported on Thursday, citing people familiar with ...
Merck’s stock fell 1.77% to $80.93 while the market gained, despite rising 5.26% over the past month. The company’s upcoming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results